Screening and Validation of a Carvacrol-Targeting Viability-Regulating Protein, SLC6A3, in Liver Hepatocellular Carcinoma.
Xieling YinHongjian ChenShi ChenSuqing ZhangPublished in: Disease markers (2022)
Carvacrol inhibited the viability of LIHC cells by downregulating SLC6A3.